TrialPanorama/TrialPanorama-database huggingface dataset:
Study 7604788 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 102115 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 18579976 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 12624556 — Surrogate Endpoint (SUR): Blood pressure
Study 6313523 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 6313523 — Surrogate Endpoint (SUR): Blood pressure
Study 6313523 — Surrogate Endpoint (SUR): Serum potassium
Study 30958879 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 19460913 — Surrogate Endpoint (SUR): Blood pressure
Study 7982727 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 29985281 — Safety Biomarker (SAF): miR-15a
Genes: MIR15A
Study 23433590 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29544162 — Surrogate Endpoint (SUR): Bone mineral density
Study 26677940 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 26677940 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12045163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7872219 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23916928 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 1499443 — Surrogate Endpoint (SUR): Blood pressure
Study 24879797 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 7094971 — Predictive Biomarker (PRD): HID1 mRNA
Genes: HID1; C17orf28; DMC1
Study 15040533 — Monitoring Biomarker (MOI): HBV DNA
Study 11438043 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study 9683174 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 16495393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 15246908 — Surrogate Endpoint (SUR): Blood pressure
Study 23557551 — Surrogate Endpoint (SUR): Blood pressure
Study 9034759 — Surrogate Endpoint (SUR): Blood pressure
Study 31036108 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 22410815 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22410815 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 7798415 — Surrogate Endpoint (SUR): Blood pressure
Study 25525862 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25525862 — Safety Biomarker (SAF): BDNF
Study 16779513 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 14569109 — Surrogate Endpoint (SUR): Bone mineral density
Study 14569109 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study 14569109 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 11016328 — Surrogate Endpoint (SUR): Serum creatinine
Study 28376080 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 28376080 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 21890886 — Surrogate Endpoint (SUR): Blood pressure
Study 29371246 — Safety Biomarker (SAF): MTHFR
Study 23131570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20128376 — Surrogate Endpoint (SUR): Blood pressure
Study 31343205 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 24676715 — Surrogate Endpoint (SUR): Blood pressure
Study 13678427 — Surrogate Endpoint (SUR): Blood pressure
Study 1533528 — Surrogate Endpoint (SUR): Blood pressure
Study 31383509 — Surrogate Endpoint (SUR): Total kidney volume
Study 21194471 — Surrogate Endpoint (SUR): Serum creatinine
Study 21194471 — Surrogate Endpoint (SUR): Bone mineral density
Study 2844467 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2844467 — Surrogate Endpoint (SUR): Blood pressure
Study 29360570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29360570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29360570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28049491 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 21177013 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 21177013 — Surrogate Endpoint (SUR): Serum creatinine
Study 16549962 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8730978 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29121408 — Surrogate Endpoint (SUR): Blood pressure
Study 29121408 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25971439 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 10619580 — Surrogate Endpoint (SUR): Blood pressure
Study 22410469 — Surrogate Endpoint (SUR): Blood pressure
Study 10487480 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25346067 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 16879517 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7658972 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 7658972 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 25449207 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 22759078 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 21724705 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 16522392 — Surrogate Endpoint (SUR): Blood pressure
Study 10903017 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 10589958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10589958 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 18268285 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 7927247 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7927247 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 7927247 — Monitoring Biomarker (MOI): HBV DNA
Study 7927247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7927247 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 7927247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 7927247 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 17990218 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 17990218 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 28991513 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 28525977 — Surrogate Endpoint (SUR): Blood pressure
Study 25899785 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25899785 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25899785 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study 23810939 — Surrogate Endpoint (SUR): Blood pressure
Study 8861665 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8861665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19300424 — Surrogate Endpoint (SUR): Blood pressure
Study 15567788 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15567788 — Surrogate Endpoint (SUR): Blood pressure
Study 3475430 — Surrogate Endpoint (SUR): Blood pressure
Study 21470872 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 19673337 — Predictive Biomarker (PRD): ACRC mRNA
Genes: GCNA; ACRC
Study 19673337 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 14559725 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22281799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22281799 — Safety Biomarker (SAF): IL-6 and IL-10
Study 27384580 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 27384580 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 17172316 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14668570 — Surrogate Endpoint (SUR): Blood pressure
Study 9797183 — Surrogate Endpoint (SUR): Blood pressure
Study 9797183 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2577283 — Surrogate Endpoint (SUR): Blood pressure
Study 23386704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15172090 — Surrogate Endpoint (SUR): Blood pressure
Study 9578967 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 24731493 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 2824031 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 28095077 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28095077 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 9126664 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24045343 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 19082329 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 12720588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12720588 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 8513908 — Surrogate Endpoint (SUR): Blood pressure
Study 2450187 — Surrogate Endpoint (SUR): Blood pressure
Study 29352306 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 16845327 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16845327 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 16845327 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 16845327 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 16845327 — Safety Biomarker (SAF): Interleukin 12
Study 16845327 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9165546 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2422479 — Surrogate Endpoint (SUR): Serum creatinine
Study 30303707 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 21955862 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21955862 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 21955862 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 9055135 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9055135 — Surrogate Endpoint (SUR): Blood pressure
Study 8417172 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8417172 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15483282 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 29126416 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 12830440 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 12830440 — Surrogate Endpoint (SUR): Serum calcium
Study 2499466 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 2499466 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 28051240 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24579084 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 24579084 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 24579084 — Predictive Biomarker (PRD): PDK4 mRNA
Genes: PDK4; PDHK4
Study 24579084 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study 22718792 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 15837236 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 28894292 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 28894292 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 28894292 — Predictive Biomarker (PRD): CPT1A mRNA
Genes: CPT1A; CPT1
Study 28894292 — Predictive Biomarker (PRD): UCP2 mRNA
Genes: UCP2; SLC25A8
Study 28894292 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study 16280286 — Surrogate Endpoint (SUR): Blood pressure
Study 7604803 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8179847 — Surrogate Endpoint (SUR): Blood pressure
Study 8179847 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 20818194 — Surrogate Endpoint (SUR): Blood pressure
Study 3928213 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 29136001 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21552185 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21552185 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 21552185 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 23900047 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 16623404 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1314871 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24104542 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18004127 — Surrogate Endpoint (SUR): Blood pressure
Study 14712422 — Surrogate Endpoint (SUR): Serum creatinine
Study 26404199 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 23722481 — Surrogate Endpoint (SUR): Blood pressure
Study 2679084 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2679084 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31937617 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study 31937617 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 31937617 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 26254792 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 12767425 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 9425505 — Surrogate Endpoint (SUR): Bone mineral density
Study 9301631 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 30257125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26562003 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25267153 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22332874 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22332874 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 22332874 — Predictive Biomarker (PRD): STIM1 mRNA
Genes: STIM1; GOK
Study 22332874 — Predictive Biomarker (PRD): PTPN22 mRNA
Genes: PTPN22; PTPN8
Study 20504126 — Surrogate Endpoint (SUR): Blood pressure
Study 10351973 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 10351973 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 6414271 — Surrogate Endpoint (SUR): Blood pressure
Study 25658497 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25658497 — Safety Biomarker (SAF): BDNF
Study 24356339 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study 24356339 — Predictive Biomarker (PRD): OGG1 mRNA
Genes: OGG1; MMH; MUTM; OGH1
Study 24356339 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 21919922 — Surrogate Endpoint (SUR): Blood pressure
Study 30069238 — Surrogate Endpoint (SUR): Bone mineral density
Study 25557266 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 23852947 — Monitoring Biomarker (MOI): HBV DNA
Study 12578874 — Surrogate Endpoint (SUR): Blood pressure
Study 26758251 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 26758251 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24652053 — Predictive Biomarker (PRD): DIS3 mRNA
Genes: DIS3; KIAA1008; RRP44
Study 12140806 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30007333 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 26729950 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26729950 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21849651 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 21849651 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 21849651 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 26431906 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 26618505 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 22124576 — Surrogate Endpoint (SUR): Bone mineral density
Study 21419314 — Surrogate Endpoint (SUR): Blood pressure
Study 29808316 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 22961097 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 22961097 — Safety Biomarker (SAF): BDNF
Study 11553182 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 9757854 — Surrogate Endpoint (SUR): Bone mineral density
Study 8151606 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2470358 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 12386042 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2309645 — Surrogate Endpoint (SUR): Serum triglycerides
Study 2309645 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27545497 — Monitoring Biomarker (MOI): HBV DNA
Study 27545497 — Surrogate Endpoint (SUR): Bone mineral density
Study 22168961 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22168961 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11748333 — Surrogate Endpoint (SUR): Bone mineral density
Study 7547078 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23645690 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 10813541 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26198842 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 23599045 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 16467415 — Surrogate Endpoint (SUR): Blood pressure
Study 8557151 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 30027607 — Surrogate Endpoint (SUR): Blood pressure
Study 30027607 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9270086 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9270086 — Surrogate Endpoint (SUR): Blood pressure
Study 12970289 — Surrogate Endpoint (SUR): Bone mineral density
Study 12970289 — Surrogate Endpoint (SUR): Serum calcium
Study 10656170 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10656170 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 10656170 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8683863 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 4013351 — Surrogate Endpoint (SUR): Blood pressure
Study 4013351 — Surrogate Endpoint (SUR): Serum potassium
Study 22733474 — Surrogate Endpoint (SUR): Serum potassium
Study 22733474 — Surrogate Endpoint (SUR): Blood pressure
Study 19949016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15867200 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30451307 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 30451307 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11838000 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 27928704 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25646817 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17378918 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 11413083 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 8111502 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29951651 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 29951651 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 3737785 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 26785220 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 11133320 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 10168532 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study 2884723 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 26268815 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 16628063 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 16628063 — Surrogate Endpoint (SUR): Blood pressure
Study 22030715 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 8847943 — Surrogate Endpoint (SUR): Serum potassium
Study 8847943 — Surrogate Endpoint (SUR): Blood pressure
Study 30277014 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 1589701 — Surrogate Endpoint (SUR): Blood pressure
Study 1589701 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3897071 — Surrogate Endpoint (SUR): Blood pressure
Study 29573567 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 17700397 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15868595 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 11998815 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 2755214 — Surrogate Endpoint (SUR): Serum potassium
Study 15120888 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15120888 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9706829 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25671796 — Surrogate Endpoint (SUR): Blood pressure
Study 3307093 — Surrogate Endpoint (SUR): Plasma testosterone level
Study 30572894 — Surrogate Endpoint (SUR): Blood pressure
Study 30572894 — Surrogate Endpoint (SUR): Serum triglycerides
Study 21905086 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 12552952 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 12552952 — Predictive Biomarker (PRD): TYMS
Genes: Tsase; TMS; HsT422